Redmile Group as of Dec. 31, 2023
Portfolio Holdings for Redmile Group
Redmile Group holds 70 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ImmunoGen | 17.4 | $487M | 16M | 29.65 | |
| Krystal Biotech (KRYS) | 7.7 | $215M | 1.7M | 124.06 | |
| Amicus Therapeutics (FOLD) | 7.5 | $210M | 15M | 14.19 | |
| Scholar Rock Hldg Corp (SRRK) | 4.3 | $120M | 6.4M | 18.80 | |
| Rayzebio | 4.1 | $116M | 1.9M | 62.17 | |
| Augmedix (AUGX) | 3.4 | $96M | 16M | 5.85 | |
| Deciphera Pharmaceuticals | 2.8 | $77M | 4.8M | 16.13 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 2.4 | $68M | 143k | 475.31 | |
| Regenxbio Inc equity us cm (RGNX) | 2.4 | $68M | 3.8M | 17.95 | |
| Biohaven (BHVN) | 2.2 | $62M | 1.4M | 42.80 | |
| Zymeworks Del (ZYME) | 2.2 | $60M | 5.8M | 10.39 | |
| Livanova SHS (LIVN) | 2.1 | $59M | 1.1M | 51.74 | |
| Alx Oncology Hldgs (ALXO) | 1.9 | $55M | 3.7M | 14.89 | |
| Catalent | 1.8 | $49M | 1.1M | 44.93 | |
| Fate Therapeutics (FATE) | 1.8 | $49M | 13M | 3.74 | |
| Pliant Therapeutics (PLRX) | 1.7 | $49M | 2.7M | 18.11 | |
| Kymera Therapeutics (KYMR) | 1.7 | $46M | 1.8M | 25.46 | |
| Immunome (IMNM) | 1.5 | $42M | 3.9M | 10.70 | |
| Immunovant (IMVT) | 1.5 | $41M | 977k | 42.13 | |
| Boston Scientific Corporation (BSX) | 1.4 | $40M | 693k | 57.81 | |
| Shattuck Labs (STTK) | 1.4 | $40M | 5.6M | 7.13 | |
| Celldex Therapeutics Com New (CLDX) | 1.4 | $39M | 994k | 39.66 | |
| Beam Therapeutics (BEAM) | 1.4 | $39M | 1.4M | 27.22 | |
| Absci Corp (ABSI) | 1.2 | $34M | 8.0M | 4.20 | |
| Nurix Therapeutics (NRIX) | 1.2 | $34M | 3.3M | 10.32 | |
| Ideaya Biosciences (IDYA) | 1.2 | $33M | 936k | 35.58 | |
| Replimune Group (REPL) | 1.2 | $33M | 3.9M | 8.43 | |
| Cabaletta Bio (CABA) | 1.1 | $31M | 1.4M | 22.70 | |
| Abbott Laboratories (ABT) | 1.0 | $29M | 266k | 110.07 | |
| Evolent Health Cl A (EVH) | 1.0 | $28M | 836k | 33.03 | |
| Akero Therapeutics (AKRO) | 0.9 | $26M | 1.1M | 23.35 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.9 | $25M | 15M | 1.66 | |
| Annexon (ANNX) | 0.9 | $25M | 5.5M | 4.54 | |
| Igm Biosciences (IGMS) | 0.9 | $25M | 3.0M | 8.31 | |
| Verve Therapeutics (VERV) | 0.9 | $24M | 1.7M | 13.94 | |
| Penumbra (PEN) | 0.9 | $24M | 95k | 251.54 | |
| 89bio (ETNB) | 0.8 | $22M | 2.0M | 11.17 | |
| Charles River Laboratories (CRL) | 0.7 | $21M | 87k | 236.40 | |
| Entrada Therapeutics (TRDA) | 0.7 | $19M | 1.3M | 15.09 | |
| Neurogene (NGNE) | 0.7 | $18M | 947k | 19.38 | |
| Intuitive Surgical Com New (ISRG) | 0.7 | $18M | 54k | 337.36 | |
| Hca Holdings (HCA) | 0.6 | $18M | 66k | 270.68 | |
| Cogent Biosciences (COGT) | 0.6 | $17M | 2.9M | 5.88 | |
| Stryker Corporation (SYK) | 0.6 | $16M | 53k | 299.46 | |
| Repare Therapeutics Ord (RPTX) | 0.6 | $16M | 2.1M | 7.30 | |
| Stoke Therapeutics (STOK) | 0.5 | $14M | 2.6M | 5.26 | |
| Align Technology (ALGN) | 0.5 | $14M | 50k | 274.00 | |
| Gritstone Oncology Ord (GRTSQ) | 0.4 | $12M | 5.9M | 2.04 | |
| Prime Medicine (PRME) | 0.4 | $12M | 1.3M | 8.86 | |
| Anthem (ELV) | 0.4 | $11M | 23k | 471.56 | |
| Allakos | 0.4 | $10M | 3.7M | 2.73 | |
| Ac Immune Sa SHS (ACIU) | 0.4 | $10M | 2.0M | 5.00 | |
| Rapt Therapeutics | 0.3 | $9.1M | 367k | 24.85 | |
| Stereotaxis Com New (STXS) | 0.2 | $6.0M | 3.4M | 1.75 | |
| Adagio Therapeutics (IVVD) | 0.2 | $5.7M | 1.4M | 3.94 | |
| Science 37 Holdings Com New | 0.2 | $5.3M | 990k | 5.34 | |
| Atara Biotherapeutics | 0.2 | $4.7M | 9.1M | 0.51 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $4.6M | 3.0M | 1.51 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.1 | $3.3M | 2.1M | 1.58 | |
| Medavail Holdings Com New (MDVLQ) | 0.1 | $3.1M | 692k | 4.41 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $2.5M | 1.0M | 2.35 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.4M | 1.6M | 0.89 | |
| Allovir (ALVR) | 0.0 | $1.3M | 1.9M | 0.68 | |
| Somalogic Class A Com | 0.0 | $938k | 371k | 2.53 | |
| Invitae (NVTAQ) | 0.0 | $924k | 1.5M | 0.63 | |
| Hookipa Pharma Inc equity | 0.0 | $862k | 1.1M | 0.81 | |
| Alpha Teknova (TKNO) | 0.0 | $601k | 161k | 3.73 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $568k | 716k | 0.79 | |
| Ventyx Biosciences (VTYX) | 0.0 | $512k | 207k | 2.47 | |
| Atreca Cl A Com (BCEL) | 0.0 | $58k | 443k | 0.13 |